These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3940528)

  • 1. The role of the gut flora in the reduction of sulphoxide containing drugs.
    Renwick AG; Strong HA; George CF
    Biochem Pharmacol; 1986 Jan; 35(1):64. PubMed ID: 3940528
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of thioredoxin in sulfoxide reduction by mammalian tissues.
    Anders MW; Ratnayake JH; Hanna PE; Fuchs JA
    Biochem Biophys Res Commun; 1980 Dec; 97(3):846-51. PubMed ID: 7470152
    [No Abstract]   [Full Text] [Related]  

  • 3. On the sulphoxidation of cimetidine and etintidine by rat and human liver microsomes.
    Schulz M; Schmoldt A
    Xenobiotica; 1988 Aug; 18(8):983-9. PubMed ID: 3142156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimethyl sulphoxide reduction by micro-organisms.
    Zinder SH; Brock TD
    J Gen Microbiol; 1978 Apr; 105(2):335-42. PubMed ID: 347031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphoxide metabolites of thioridazine in man.
    Papadopoulos AS; Crammer JL
    Xenobiotica; 1986 Dec; 16(12):1097-107. PubMed ID: 3798957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfoxide reduction: in vitro reduction of oxyprothepine-8-sulfoxide by rat hepatic cytosolic and microsomal enzymes.
    Helia O; Pauliková I
    Pharmazie; 1993 Oct; 48(10):784-5. PubMed ID: 7903462
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of a synthetic diet on the pharmacokinetics of ethyl methyl sulphide and its sulphoxide and sulphone metabolites in rats.
    Nnane LP; Damani LA; Hutt AJ
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):17-24. PubMed ID: 11554429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Formation of optically active sulfoxides in the metabolism of p-thioanisidine].
    Kexel H; Schmidt HL
    Biochem Pharmacol; 1972 Apr; 21(7):1009-17. PubMed ID: 5039747
    [No Abstract]   [Full Text] [Related]  

  • 9. Sulfoxide reduction in relation to organophosphorus insecticide detoxification.
    DeBaun JR; Menn JJ
    Science; 1976 Jan; 191(4223):187-8. PubMed ID: 1246606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The metabolism of albendazole in the isolated perfused intestine of rats].
    Lawrenz A; Eglit S; Kroker R
    Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):416-8. PubMed ID: 1425320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiolactone sulfoxides as new reactive metabolites acting as bis-electrophiles: implication in clopidogrel and prasugrel bioactivation.
    Dansette PM; Levent D; Hessani A; Bertho G; Mansuy D
    Chem Res Toxicol; 2013 May; 26(5):794-802. PubMed ID: 23527615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotechnological production of chiral organic sulfoxides: current state and perspectives.
    Matsui T; Dekishima Y; Ueda M
    Appl Microbiol Biotechnol; 2014 Sep; 98(18):7699-706. PubMed ID: 25073518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction by the gut microflora of animals and man.
    Rowland IR
    Biochem Pharmacol; 1986 Jan; 35(1):27-32. PubMed ID: 3510060
    [No Abstract]   [Full Text] [Related]  

  • 14. Chiral inversion of drug: role of intestinal bacteria in the stereoselective sulphoxide reduction of flosequinan.
    Kashiyama E; Yokoi T; Todaka T; Odomi M; Kamataki T
    Biochem Pharmacol; 1994 Jul; 48(2):237-43. PubMed ID: 8053920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly enantioselective oxidation of phenyl methyl sulfide and its derivatives into optically pure (S)-sulfoxides with Rhodococcus sp. CCZU10-1 in an n-octane-water biphasic system.
    He YC; Ma CL; Yang ZX; Zhou M; Xing Z; Ma JT; Yu HL
    Appl Microbiol Biotechnol; 2013 Dec; 97(24):10329-37. PubMed ID: 24092008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in albendazole sulphonation during experimental fascioliasis in sheep.
    Galtier P; Alvinerie M; Plusquellec Y; Tufenkji AE; Houin G
    Xenobiotica; 1991 Jul; 21(7):917-24. PubMed ID: 1776267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial dioxygenase- and monooxygenase-catalysed sulfoxidation of benzo[b]thiophenes.
    Boyd DR; Sharma ND; McMurray B; Haughey SA; Allen CC; Hamilton JT; McRoberts WC; O'Ferrall RA; Nikodinovic-Runic J; Coulombel LA; O'Connor KE
    Org Biomol Chem; 2012 Jan; 10(4):782-90. PubMed ID: 22134441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, metabolism and excretion of di(rho-aminophenyl) sulphone (dapsone) and di(rho-aminophenyl) sulphoxide in man.
    Ellard GA
    Br J Pharmacol Chemother; 1966 Jan; 26(1):212-7. PubMed ID: 5919504
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of prothionamide and ethionamide and their sulfoxides in blood plasma].
    Pütter J
    Arzneimittelforschung; 1972 Jun; 22(6):1027-31. PubMed ID: 4262015
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel pathway for formation of thiol metabolites and cysteine conjugates from cysteine conjugate sulphoxides.
    Tomisawa H; Hayashi M; Fukushima M; Iida S; Uda F; Hattori K; Tateishi M
    Biochem Pharmacol; 1993 Oct; 46(7):1113-7. PubMed ID: 8216359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.